Current and emerging medications for overweight or obesity in people with comorbidities
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Current and emerging medications for overweight or obesity in people with comorbidities
Authors
Keywords
-
Journal
DIABETES OBESITY & METABOLISM
Volume 17, Issue 11, Pages 1021-1032
Publisher
Wiley
Online
2015-06-04
DOI
10.1111/dom.12502
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy and safety of beloranib for weight loss in obese adults: a randomized controlled trial
- (2015) D. D. Kim et al. DIABETES OBESITY & METABOLISM
- AACE/ACE COMPREHENSIVE DIABETES MANAGEMENT ALGORITHM 2015
- (2015) Alan J. Garber et al. Endocrine Practice
- Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline
- (2015) Caroline M. Apovian et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Lixisenatide as add-on to oral anti-diabetic therapy: an effective treatment for glycaemic control with body weight benefits in type 2 diabetes
- (2014) Denis Raccah et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Reductions in systolic blood pressure with liraglutide in patients with type 2 diabetes: Insights from a patient-level pooled analysis of six randomized clinical trials
- (2014) Vivian A. Fonseca et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Cardiovascular effects of phentermine and topiramate
- (2014) Jens Jordan et al. JOURNAL OF HYPERTENSION
- Design of the liraglutide effect and action in diabetes: Evaluation of cardiovascular outcome results (LEADER) trial
- (2013) Steven P. Marso et al. AMERICAN HEART JOURNAL
- The Long-term Effectiveness of a Lifestyle Intervention in Severely Obese Individuals
- (2013) Jessica L. Unick et al. AMERICAN JOURNAL OF MEDICINE
- Are Metabolically Healthy Overweight and Obesity Benign Conditions?
- (2013) Caroline K. Kramer et al. ANNALS OF INTERNAL MEDICINE
- Prevention of Type 2 Diabetes in Subjects With Prediabetes and Metabolic Syndrome Treated With Phentermine and Topiramate Extended Release
- (2013) W. Timothy Garvey et al. DIABETES CARE
- Effects of Naltrexone Sustained- Release/Bupropion Sustained-Release Combination Therapy on Body Weight and Glycemic Parameters in Overweight and Obese Patients With Type 2 Diabetes
- (2013) P. Hollander et al. DIABETES CARE
- Combination therapy with naltrexone and bupropion for obesity reduces total and visceral adiposity
- (2013) S. R. Smith et al. DIABETES OBESITY & METABOLISM
- Efficacy and safety of sodium glucose co-transport-2 inhibitors in type 2 diabetes: a meta-analysis of randomized clinical trials
- (2013) M. Monami et al. DIABETES OBESITY & METABOLISM
- Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite and energy metabolism in obese, non-diabetic adults
- (2013) J van Can et al. INTERNATIONAL JOURNAL OF OBESITY
- Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: The SCALE Maintenance randomized study
- (2013) T A Wadden et al. INTERNATIONAL JOURNAL OF OBESITY
- Association of All-Cause Mortality With Overweight and Obesity Using Standard Body Mass Index Categories
- (2013) Katherine M. Flegal et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Review of the key results from the Swedish Obese Subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery
- (2013) L. Sjöström JOURNAL OF INTERNAL MEDICINE
- Canagliflozin: Effects in overweight and obese subjects without diabetes mellitus
- (2013) Harold E. Bays et al. Obesity
- The progression of cardiometabolic disease: Validation of a new cardiometabolic disease staging system applicable to obesity
- (2013) Fangjian Guo et al. Obesity
- A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity-related risk factors (COR-II)
- (2013) Caroline M. Apovian et al. Obesity
- The Clinical Efficacy and Safety of Sodium Glucose Cotransporter-2 Inhibitors in Adults with Type 2 Diabetes Mellitus
- (2013) Shawn Riser Taylor et al. PHARMACOTHERAPY
- Bariatric Surgery as a Highly Effective Intervention for Diabetes: News Flash or Preaching to the Choir?
- (2012) Jon C. Gould ARCHIVES OF SURGERY
- Weight change with liraglutide and comparator therapies: an analysis of seven phase 3 trials from the liraglutide diabetes development programme
- (2012) K. Niswender et al. DIABETES OBESITY & METABOLISM
- Improved lifestyle and decreased diabetes risk over 13 years: long-term follow-up of the randomised Finnish Diabetes Prevention Study (DPS)
- (2012) J. Lindström et al. DIABETOLOGIA
- American Association of Clinical Endocrinologists' Position Statement on Obesity and Obesity Medicine
- (2012) Jeffrey Mechanick et al. Endocrine Practice
- Association of an Intensive Lifestyle Intervention With Remission of Type 2 Diabetes
- (2012) Edward W. Gregg et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Randomized Placebo-Controlled Clinical Trial of Lorcaserin for Weight Loss in Type 2 Diabetes Mellitus: The BLOOM-DM Study
- (2012) Patrick M. O'Neil et al. Obesity
- A Randomized, Double-Blind, Placebo-Controlled Study of an Oral, Extended-Release Formulation of Phentermine/Topiramate for the Treatment of Obstructive Sleep Apnea in Obese Adults
- (2012) David H. Winslow et al. SLEEP
- Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study
- (2011) W Timothy Garvey et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Pragmatic study of orlistat 60 mg on abdominal obesity
- (2011) E L Thomas et al. EUROPEAN JOURNAL OF CLINICAL NUTRITION
- Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide
- (2011) A Astrup et al. INTERNATIONAL JOURNAL OF OBESITY
- A One-Year Randomized Trial of Lorcaserin for Weight Loss in Obese and Overweight Adults: The BLOSSOM Trial
- (2011) Meredith C. Fidler et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial
- (2011) Kishore M Gadde et al. LANCET
- Blood Pressure and Heart Rate Effects, Weight Loss and Maintenance During Long-Term Phentermine Pharmacotherapy for Obesity
- (2011) Ed J. Hendricks et al. Obesity
- Controlled-Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP)
- (2011) David B. Allison et al. Obesity
- Effects of Exenatide and Lifestyle Modification on Body Weight and Glucose Tolerance in Obese Subjects With and Without Pre-Diabetes
- (2010) J. Rosenstock et al. DIABETES CARE
- Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management
- (2010) Steven R. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- Weight Loss With Naltrexone SR/Bupropion SR Combination Therapy as an Adjunct to Behavior Modification: The COR-BMOD Trial
- (2010) Thomas A. Wadden et al. Obesity
- Depression and obesity: A meta-analysis of community-based studies
- (2010) Leonore de Wit et al. PSYCHIATRY RESEARCH
- High prevalence of obesity, central obesity and abnormal glucose tolerance in the middle-aged Finnish population
- (2009) Timo E Saaristo et al. BMC PUBLIC HEALTH
- A proposed clinical staging system for obesity
- (2009) A M Sharma et al. INTERNATIONAL JOURNAL OF OBESITY
- Comparison of Combined Bupropion and Naltrexone Therapy for Obesity with Monotherapy and Placebo
- (2009) Frank L. Greenway et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study
- (2009) LANCET
- Comorbidities of Obesity
- (2009) Kavitha Bhat Schelbert PRIMARY CARE
- The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study
- (2008) Guangwei Li et al. LANCET
- Obesity as a Disease: The Obesity Society Council Resolution
- (2008) Obesity
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started